__NUXT_JSONP__("/drugs/Porfimer_Sodium", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[{brand:"Photofrin",indication:"1 INDICATIONS AND USAGE PHOTOFRIN is a photoactivated radical generator indicated for: Esophageal Cancer ( 1.1 ) Palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their physician, cannot be satisfactorily treated with Nd:YAG laser therapy Endobronchial Cancer ( 1.2 ) Treatment of microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated Reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial NSCLC High-Grade Dysplasia in Barrett’s Esophagus ( 1.3 ) Ablation of high-grade dysplasia (HGD) in Barrett’s esophagus (BE) patients who do not undergo esophagectomy 1.1 Esophageal Cancer PHOTOFRIN ® is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their healthcare provider, cannot be satisfactorily treated with Nd:YAG laser therapy. 1.2 Endobronchial Cancer PHOTOFRIN is indicated for the treatment of microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated. PHOTOFRIN is indicated for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial NSCLC. 1.3 High-Grade Dysplasia in Barrett’s Esophagus PHOTOFRIN is indicated for the ablation of high-grade dysplasia in Barrett’s esophagus patients who do not undergo esophagectomy.",manufacturer:"Pinnacle Biologics, Inc.",splSetId:"5c4841b4-fbc0-4163-8ee1-cb28629cbfbf"}],id:a,nciThesaurus:{casRegistry:"87806-31-3",chebiId:"CHEBI:60773",chemicalFormula:"(C34H35N4NaO5)n.(C34H33N4NaO4)n",definition:"The sodium salt of a mixture of oligomers formed by ether and ester linkages of up to eight porphyrin units with photodynamic activity. Absorbed selectively by tumor cells, porfimer produces oxygen radicals after activation by 630 nm wavelength laser light, resulting in tumor cell cytotoxicity. In addition, tumor cell death may occur due to ischemic necrosis secondary to vascular occlusion that appears to be partly mediated by the release of thromboxane A2.",fdaUniiCode:"Y3834SIK5F",identifier:"C1071",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C1420"],synonyms:["CL-184116","DHE","Dihematoporphyrin Ester","Dihematoporphyrin Ether","PORFIMER SODIUM","Photofrin II",b,"dihematoporphyrin ether","porfimer sodium"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPorfimer_Sodium",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Porfimer_Sodium","Porfimer Sodium","2021-10-30T13:18:00.353Z")));